Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 12-2005 | 12-1998 | 12-1997 | 12-1996 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | 7,510 | 11,830 | 8,064 |
| Depreciation Amortization | N/A | N/A | 10,530 | 9,519 | 7,896 |
| Other Working Capital | N/A | N/A | -5,280 | 6,361 | -22,676 |
| Other Operating Activity | 0 | 0 | 3,180 | -9,209 | -46,267 |
| Operating Cash Flow | $N/A | $N/A | $15,940 | $18,501 | $-52,983 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -29,000 | -30,971 | -29,312 |
| Net Acquisitions | N/A | N/A | 0 | -2,019 | 261,752 |
| Other Investing Activity | 0 | 0 | -12,580 | -2,915 | -1,803 |
| Investing Cash Flow | $N/A | $N/A | $-41,580 | $-35,905 | $230,637 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | N/A | N/A | -12,020 | -11,501 | -11,174 |
| Other Financing Activity | 0 | 0 | 36,260 | 29,981 | -165,983 |
| Financing Cash Flow | $N/A | $N/A | $24,240 | $18,480 | $-177,157 |
| Beginning Cash Position | N/A | N/A | 2,200 | 1,126 | 629 |
| End Cash Position | N/A | N/A | 800 | 2,202 | 1,126 |
| Net Cash Flow | $N/A | $N/A | $-1,390 | $1,076 | $497 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | N/A | 15,940 | 18,501 | -52,983 |
| Free Cash Flow | 0 | 0 | 15,940 | 18,501 | -52,983 |